RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

NCT03524430 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
801
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Rna Diagnostics Inc.